Biomarkers
What Is PD-L1 and Why Does It Matter?
PD-L1 is a biomarker that helps determine whether immunotherapy will work for your cancer. Learn what PD-L1 testing means and how results affect treatment.
What Is HER2-Positive Breast Cancer?
HER2-positive breast cancer is an aggressive subtype driven by excess HER2 protein. Learn about HER2 testing, targeted therapies, and what this diagnosis means.
What Is MSI-High Cancer?
MSI-H (microsatellite instability-high) is a biomarker that predicts exceptional response to immunotherapy across many cancer types. Here's what it means and why it matters.
What Is HER2? A Patient's Guide
HER2 is a protein that drives growth in certain cancers. Being HER2-positive opens access to powerful targeted therapies. Here's what you need to know.
Take Control of Your Cancer Journey
OncoNav helps patients understand their diagnosis, prepare for appointments, organize medical information, and track their treatment journey.